GRUPO FINANCIERO GALICIA SA
GGALAbout the company
Grupo Financiero Galicia S.A., a financial service holding company, provides various financial products and services to individuals and companies in Argentina. The company operates through Bank, Naranja X, Insurance, and Other Businesses segments. It offers savings, checking, and time deposits; and credit and debit cards.
Investment snapshot
Positive
6
BUY / PASS
Neutral / negative
6 / 4
NEUTRAL / FAIL
Median fair value
$16.04
-46.1% vs price
Models with upside
6 / 16
Positive margin of safety
Strongest signal
GGAL undervalued: all 6 models price fair value above $29.75 (median $16.04)
Key risk
Split decision: 6 NEUTRAL · 5 BUY · 4 FAIL · 1 PASS
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | PASS | FAIL | BUY | NEUTRAL | NEUTRAL | BUY | BUY | NEUTRAL | NEUTRAL | FAIL | BUY | FAIL | NEUTRAL | FAIL | BUY | NEUTRAL |
| Score | ||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||||
| Margin of Safety | +69.4% | N/A | +88.8% | N/A | +79.8% | N/A | +82.9% | +91.2% | N/A | N/A | +35.2% | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | Annual history · FY 2024 Latest source filing: 2025-04-28 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-04-28 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-04-28 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-04-28 Score computed: 2026-11-14 | Annual history · FY 2024 · Market data at 2026-11-01 Latest source filing: 2025-04-28 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2024 Latest source filing: 2025-04-28 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2024 Latest source filing: 2025-04-28 Score computed: 2026-11-14 | Annual history · FY 2024 · Qualitative assessment Latest source filing: 2025-04-28 Score computed: 2026-11-14 | Annual history · FY 2024 · Qualitative assessment Latest source filing: 2025-04-28 Score computed: 2026-11-14 | Annual history · FY 2024 · Market data at 2026-11-01 Latest source filing: 2025-04-28 Score computed: 2026-11-14 | Annual history · FY 2024 · Price history 2025-01-01–2026-11-01 Latest source filing: 2025-04-28 Score computed: 2026-11-14 | Annual history · FY 2024 · Qualitative assessment Latest source filing: 2025-04-28 Score computed: 2026-11-14 | Annual history · FY 2024 · Price history 2025-01-01–2026-11-01 Latest source filing: 2025-04-28 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-04-28 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-04-28 Score computed: 2026-11-14 | Annual history · FY 2024 · Price history 2025-01-01–2026-11-01 Latest source filing: 2025-04-28 Score computed: 2026-11-14 |
Where It Passes
- Valuation models100% pass✓ 6▾
GGAL undervalued: all 6 models price fair value above $29.75 (median $16.04)
Graham fair value$9.74✓Graham+69.4% margin vs $29.75Lynch fair value$26.56✓Lynch+88.8% margin vs $29.75Dreman fair value$14.71✓Dreman+79.8% margin vs $29.75Pabrai fair value$17.37✓Pabrai+82.9% margin vs $29.75Akre fair value$33.74✓Akre+91.2% margin vs $29.75Templeton fair value$4.59✓Templeton+35.2% margin vs $29.75 - Valuation83% pass✓ 22✗ 4▾
10 of 12 pass — Ackman and Oshaughnessy object
Price / 3-yr avg EPS5.8x✓Graham<= 15xPrice-to-Tangible-Book Ratio0.8x✓Graham<= 1.5xP/E x P/TBV4.60✓Graham<= 22.5Basic earnings-growth PEG (dividends excluded)0.09✓Lynch< 1.0 (ideally < 0.5)Price / EPS2.8x✓Dreman< 12x✓Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)1.3x✓Dreman< 8xPrice / Tangible Book Value per Share0.8x✓Dreman< 1.2x✓SchlossP/TBV <= 1.00x (app cutoff)Valuation ReasonablenessP/E=2.8x✓MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldP/E=2.8x✓PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/E=2.8x, P/B=0.8x✓MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value61.2% (IV=$7.66 vs Price=$2.98)✓Marks>= 20% below intrinsic valuePrice / FCF per Share✗Ackman<= 25Price vs. Trailing Low108% of trailing low ($2.76)✓Templeton<= 120% of trailing low (certified split-adjusted live window)Price / Book Value per Share0.8x✓Templeton< 1.5x✓SchlossP/B <= 0.80x (app cutoff)Net income / market capitalization+31.26%; #193/6340 (top 3.0%)✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-sectionPositive book equity / market capitalization+1.1667; #1250/6449 (top 19.4%)✓AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS2.8x✓NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E15.83✓Neff> 0.7 (Neff's published traditional edge)Book Value per Share Change+118.4%✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date-38.18%; #4733/6202 (top 76.3%)✗OshaughnessyTop 10% of eligible cross-section - Debt & Leverage75% pass✓ 4✗ 1▾
3 of 4 pass — Schloss objects
LT Debt / Total Assets Change0.00% -> 0.00%✓PiotroskiDecreased YoYTotal Debt / Shareholders' Equity0.07✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00xNegative debt-to-equity (higher means less debt)-0.0729; #1150/4210 (top 27.3%)✓AsnessTop 30% of eligible cross-sectionCurrent Assets / Current Liabilities✗SchlossCurrent ratio >= 1.50x (app cutoff) - Efficiency67% pass✓ 2✗ 1▾
2 of 3 pass — Piotroski objects
Revenue / Total Assets Change YoY✗PiotroskiImproved YoYReinvestment Rate x ROIC16.7% (RR=62% x ROIC=26.8%)✓AkreReinvestment Rate * ROIC > 10%ROE (5-year)5/5 years above 12% (latest 26.8%)✓SleepROE > 12% in a majority of years - Verdicts60% pass✓ 6✗ 4▾
Split decision: 6 NEUTRAL · 5 BUY · 4 FAIL · 1 PASS
Overall verdict✓GrahamPASS (3/7)✗BuffettFAIL (1/6)✓LynchBUY (3/4)•PiotroskiNEUTRAL (F-Score 5)•DremanNEUTRAL (6/9)✓MungerBUY (3/3)✓PabraiBUY (3/3)•AkreNEUTRAL (3/5)•MarksNEUTRAL (3/4)✗AckmanFAIL (2/8)✓TempletonBUY (7/8)✗SleepFAIL (2/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (3/6)✓SchlossBUY (6/7)•OshaughnessyNEUTRAL (Not ranked)
Where It Falls Short
- Growth38% pass✓ 4✗ 8▾
5 of 8 flag GGAL's growth — Graham, Dreman, Ackman +2 more
EPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)0.09✓Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR30.8%✓Lynch15-30% (Fast Grower); > 0% to passEPS Growth Direction✗DremanPositive over recent yearsEPS CAGR✗Dreman> 5% annualizedPositive Net Income Frequency7/8 years positive✓MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth✗Ackman>= 5%Positive EPS Growth Frequency2/5 years with positive EPS growth✗AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR30.8% CAGR over 5 years✓Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trend✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR✗SleepCAGR > 7%3-5 Year Diluted EPS CAGR30.8% over 5 years✗Neff7%-20% annualized - Cash Flow40% pass✓ 5✗ 7▾
6 of 10 flag GGAL's cash flow — Buffett, Lynch, Marks +3 more
Free Cash Flow Proxy✗BuffettPositive and growingFCF Positive and Growing✗LynchPositive and growingOperating Cash Flow$3.4B✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=10.77%, ROA=5.00%✓PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)1.3x✓Dreman< 8xP/E or FCF YieldP/E=2.8x✓PabraiP/E < 15 or FCF Yield > 10%FCF Positive✗MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap✗Ackman>= 4%Price / FCF per Share✗Ackman<= 25Positive Operating Cash Flow frequency6/8 years positive✓SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures✗Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization✗OshaughnessyTop 10% of eligible cross-section - Profitability50% pass✓ 22✗ 13▾
8 of 16 pass — Graham, Buffett, Dreman +5 more object
Positive EPS (10 years)7/9 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthNet Income Positive (10+ years)7/9 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)23.9%✓Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)✗BuffettStable or rising over 10 yearsFree Cash Flow Proxy✗BuffettPositive and growingEarnings Variance (10-yr CoV)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)0.09✓Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR30.8%✓Lynch15-30% (Fast Grower); > 0% to passROE26.8%✓Lynch> 15%Net Income / Total Assets5.00%✓PiotroskiROA > 0ROA Change YoY3.30% -> 5.00% (delta: +1.70%)✓PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=10.77%, ROA=5.00%✓PiotroskiCFO/Assets > ROAPre-Tax Income / Revenue✗Dreman>= 8%Net Income / Shareholders' Equity26.8%✓Dreman> 12%Return on Equity26.8%✓Munger> 15%✓AkreROE > 20% (3-year avg)Margin of SafetyP/E=2.8x, P/TBV=0.8x✓PabraiP/TBV < 1.5 or P/E < 15ROE (high and growing)FY2022: ROE=17.4%; FY2023: ROE=16.7%; FY2024: ROE=26.8%✓AkreLatest 3 consecutive FYs: ROE > 15% in eachDiscount to Intrinsic Value61.2% (IV=$7.66 vs Price=$2.98)✓Marks>= 20% below intrinsic valuePositive Net Income Frequency7/8 years positive✓MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue✗Ackman>= 15%Net Income / Shareholders Equity26.8%✓Ackman>= 15%5-Year EPS CAGR30.8% CAGR over 5 years✓Templeton> 0% (5-year EPS CAGR)Operating Margin Trend✗TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trend✗SleepRevenue rising; gross margin flat or falling; operating margin holdingROE (5-year)5/5 years above 12% (latest 26.8%)✓SleepROE > 12% in a majority of yearsNet income / market capitalization+31.26%; #193/6340 (top 3.0%)✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-sectionGross profit / total assets✗AsnessTop 30% of eligible cross-sectionNet income / positive book equity+26.80%; #539/5226 (top 10.3%)✓AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.0101; #827/5884 (top 14.1%)✓AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR30.8% over 5 years✗Neff7%-20% annualizedPositive Diluted-EPS Years7/8 years positive✓Schloss>= 70% positive over 5-10 observed years (app rule)
Business & financials
Financial snapshot: annual FY 2024. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Leverage is a bank’s business model and current accounts don’t exist on its balance sheet, so debt and liquidity tests are omitted and tangible book value and ROE replace their industrial analogs.
Shareholder Return
Fiscal 2024
Issued 0.6% of shares last year, 0.6% issued over two.
- Buybacks
- —
- Dividends
- $596.5M
What drove EPS
A buyback raises earnings per share without the company earning more. This splits each year's change into the two.
The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.
Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
| Metric | FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
| FY 2020Sources
|
|---|---|---|---|---|---|
| Market Cap | $5.0Bcurrent | $28.6Best. | $16.4Best. | $11.2Best. | $8.4Best. |
| Revenue | -- | -- | -- | -- | -- |
| Operating Income | $1.4B↓1% | $1.5B↓42% | $2.5B↓10% | $2.8B↑73% | $1.6B |
| Net Income | $1.6B↑73% | $908.7M↓51% | $1.9B↑1% | $1.8B↑109% | $879.6M |
| EPS (Diluted) | $1.06↑276% | $0.28↑52% | $0.19↓9% | $0.21↓1% | $0.21 |
| Gross Margin | — | — | — | — | — |
| Operating Margin | — | — | — | — | — |
| ROE | 26.8%↑60% | 16.7%↓4% | 17.4%↓45% | 31.8%↑18% | 26.9% |
| Total Debt | $428.5M↑15% | $372.3M↓44% | $659.8M↑47% | $449.8M↑81% | $248.2M |
| Shareholders' Equity | $5.9B↑8% | $5.4B↓49% | $10.7B↑86% | $5.8B↑77% | $3.3B |
| Current Ratio | — | — | — | — | — |
| Debt / Equity | 0.07↑6% | 0.07↑11% | 0.06↓21% | 0.08↑3% | 0.08 |
| Operating Cash Flow | $3.4B↓24% | $4.5B↓80% | $22.1B↑32% | $16.7B↑160% | $6.4B |
| Free Cash Flow | -- | -- | -- | -- | -- |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Banking
GGAL vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MITSUBISHI UFJ FINANCIAL GROUP INCMUFG | $245.7B | $21.83 | $74.2B | $10.8B | 8.8% | 1.12 | 19.9% | — | 2/7 | 1/6 | 1/4 | F-Score 5 | 3/9 |
| AMERICAN EXPRESS COAXP | $215.0B | $320.60 | $41.3B | $10.8B | 32.4% | 1.68 | — | — | 2/7 | 3/6 | 3/4 | F-Score 4 | 3/9 |
| Banco Santander, S.A.SAN | $175.9B | $12.21 | — | $16.6B | 12.5% | 0.02 | — | — | 2/7 | 1/6 | 2/4 | F-Score 4 | 5/9 |
| BARCLAYS BANK PLCATMP | $82.1B | $35.04 | $13.1B | $6.3B | 7.5% | 0.01 | — | — | 2/7 | 1/6 | 0/4 | F-Score 7 | 4/9 |
| BARCLAYS PLCBCS | $76.0B | $22.87 | $15.0B | $9.7B | 9.2% | 0.02 | — | — | 1/7 | 0/6 | 0/4 | F-Score 7 | 2/9 |
| FIRST CITIZENS BANCSHARES INC /DE/FCNCA | $25.7B | $2324.25 | $9.5B | $2.2B | 9.9% | 1.62 | — | — | 5/7 | 3/6 | 1/4 | F-Score 5 | 2/9 |
| KEYCORP /NEW/KEY | $22.7B | $21.46 | $7.5B | $1.8B | 9.0% | 0.49 | — | — | 2/7 | 1/6 | 1/4 | F-Score 6 | 4/9 |
| WEBSTER FINANCIAL CORPWBS | $12.6B | $77.57 | $2.9B | $1.0B | 10.6% | 0.08 | 50.7% | — | 2/7 | 1/6 | 1/4 | F-Score 7 | 2/9 |